Melqart Asset Management (Uk) LTD Qiagen N.V. Transaction History

Melqart Asset Management (Uk) LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$40.9 - $50.42 $795,750 - $980,971	19,456 Added 16.38%	138,256 $5.71 Million
Q2 2022 Aug 15, 2022	SELL	$42.98 - $49.77 $567,336 - $656,964	-13,200 Reduced 10.0%	118,800 $5.61 Million
Q1 2021 May 17, 2021	BUY	$46.25 - $56.02 $6.11 Million - $7.39 Million	132,000 New	132,000 $6.43 Million
Q3 2020 Nov 16, 2020	SELL	$42.51 - $52.42 $12.6 Million - $15.5 Million	-295,700 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.49 - $44.36 $11.7 Million - $13.1 Million	295,700 New	295,700 $12.7 Million

Q1 2020 May 15, 2020	SELL	$33.17 - $41.6 $12.3 Million - $15.4 Million	-370,600 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$25.41 - $43.1 $9.42 Million - $16 Million	370,600 New	370,600 $12.5 Million

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.24B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Melqart Asset Management (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Melqart Asset Management (Uk) LTD with notifications on news.